More can be done to address cost of prescription meds - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
August 6, 2026 Newswires
Share
Share
Post
Email

More can be done to address cost of prescription meds

CARL SCHMIDNews Enterprise

Most adult Americans take at least one prescription drug, and for too many, getting that prescription filled means battling the very system that's supposed to help them.

Insurance denials have become alarmingly routine. A recent study found that 70% of commercially insured patients face initial claim rejections for new branded medicines. And even when patients manage to access treatment, affordability remains a major challenge: nearly 60% of U.S. adults worry about being able to pay for their medications.

At the center of this crisis are the abusive practices of corporate middlemen. America's vertically integrated mega-insurers and their subsidiary pharmacy benefit managers, known in the business as PBMs, have grown to control virtually every aspect of healthcare and deliberately erected administrative barriers that delay care and inflate costs – barriers felt most acutely by patients managing serious chronic conditions.

Take prior authorization. Many insurers require that providers obtain their approval before prescribing or supplying a medicine. For patients with chronic conditions, this requirement can be especially burdensome – four in 10 insured adults within this patient population say prior authorization is among their greatest healthcare challenges.

Then there are copay accumulator programs. Large insurers and PBMs often exclude manufacturer copay assistance from counting toward a patient's deductible or out-of-pocket maximum. That allows them to effectively "double dip," pocketing the copay assistance while still collecting payments from patients.

These middlemen also designate certain drugs as "non-essential" in order to exploit drugmakers' copay assistance programs. By doing so, they dodge certain federal cost-sharing protections and pocket additional funds while squeezing patients.

The effects on patient care are significant. Nearly 95% of doctors say that prior authorization causes delays in accessing necessary care. And one in three physicians reports that insurer delays led to severe events, including hospitalizations and permanent impairments.

For patients living with chronic conditions, those delays are especially dangerous. Their health depends on timely, consistent access to treatment.

Consider people living with HIV. They need continuous access to antiretroviral therapy to keep the viral load in their bodies low. Otherwise, they could develop AIDS. Higher viral loads increase the risk of transmission to other people as well – a major public health concern.

President Trump and his administration can do more in standing up for patients and protecting their access to life-saving treatment.

It could do so by enforcing or codifying a 2023 court decision requiring insurers to apply manufacturer copay assistance toward patients' cost-sharing obligations.

Alongside that effort, the administration must ensure that all drugs covered by employer health plans be designated "essential health benefits," as is already required in the small group and individual health markets. They can also champion bipartisan legislation like the Help Ensure Lower Patient (HELP) Copays Act, which would rein in insurers' and PBMs' abuse of "non-essential" drug designations and ensure copay assistance actually lowers patients' out-of-pocket costs.

President Trump has made reducing healthcare costs and barriers to care a priority. He can further deliver on that promise by curtailing these price-gouging insurance middlemen schemes and putting patients first.

Carl Schmid is executive director of the HIV+Hepatitis Policy Institute and originally ran in the Washington Examiner.

Older

The Fed needs to start listening to normal people

Newer

Wasserman: Executive order pitfalls

Advisor News

  • NAIFA applauds final SECURE 2.0 regulations
  • What will Democrats in Congress do about healthcare and retirement?
  • Election results cloud retirement legislation outlook, experts say
  • Planning for the missing chapter
  • Semi-retirement: helping clients balance flexibility with financial security
More Advisor News

Annuity News

  • ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
  • Jackson Launches Direct-to-Consumer Annuity Offering
  • Global Atlantic launches ForeIncome Flex
  • Athene CEO criticizes offshore reinsurance, risk-taking by competitors
  • DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
More Annuity News

Health/Employee Benefits News

  • CRUSH Rule could crush health insurance agents, industry group says
  • Despite rising healthcare costs, enrollment on Nevada insurance exchange is 'pretty steady'
  • REP. ONDER INTRODUCES THE ALLERGY AND ASTHMA PATIENT PROTECTION ACT
  • Forms, phone calls and portals: The hidden work that keeps American institutions functioning burdens parents most
  • What will Democrats in Congress do about healthcare and retirement?
More Health/Employee Benefits News

Life Insurance News

  • California’s new solvency rules: What should life insurance advisors watch?
  • Navigating delayed death certificates: A guide for life insurance advisors
  • Jackson Launches Direct-to-Consumer Annuity Offering
  • Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Non-Life Insurance Segment
  • AM Best Affirms Credit Ratings of Fubon Insurance Vietnam Co., Ltd.
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • OpenRoad Insurance Data Shows 40% of Collector Vehicles Are Model Year 1980 or Newer
  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.